Rafael Hernani

14PUBLICATIONS
66CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersRegenerative medicine (incl. stem cells)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jan 26, 2026
Microbiome-Based Modeling of CAR-T Therapy Response in Lymphoma: Insights From Shotgun Metagenomics Sequencing.

Rafael Hernani, Eliseo Albert, Carlos Hernani-Morales

|Oct 07, 2025
Patterns of immune recovery after axicabtagene ciloleucel for aggressive B-cell lymphoma.

André Airosa Pardal, Ana Benzaquén, Pablo Granados

|Oct 01, 2025
Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy.

Anna Torrent, Mireia Morgades, Gloria Iacoboni

|Sep 12, 2025
Pre-infusion cytomegalovirus T-cell immunity for predicting the risk of virus DNAemia in patients undergoing chimeric antigen receptor T-cell therapies.

Eliseo Albert, Rafael Hernani, Estela Giménez

|Mar 22, 2025
Early ribavirin reduce RSV symptoms duration in post-allogeneic stem cell transplant: challenges in symptoms duration assessment.

José Luis Piñana, Mireia Micó-Cerdà, Dolores Gómez

|Mar 20, 2025
Clinical Impact of CD19 Expression Assessed by Quantitative PCR in Lymphoma Patients Undergoing CAR-T Therapy.

Rafael Hernani, Laura Ventura, Begoña Heras

Pageof 3

Frequent Collaborators

6 joint publications

Juan Montoro Gómez

5 joint publications

Carlos Solano

4 joint publications

David Navarro

4 joint publications

Christelle Ferrà